Nobivac Canine 3-DA (Canada)

Manufacturer: Merck Animal Health

Canine Distemper-adenovirus Type 2 Vaccine

Modified Live Virus

For Veterinary Use In Dogs Only

In The Absence Of A Veterinarian-client-patient Relationship, U.s. Federal Regulations Prohibit The Relabeling, Repackaging, Resale Or Redistribution Of The Individual Contents Of This Package.

THIMEROSAL FREE

Product Description

Nobivac^® Canine 3-DA is a modified live virus vaccine containing attenuated strains of canine distemper virus (CDV) and adenovirus type 2 (CAV-2). This vaccine is for vaccination of healthy dogs for prevention of disease caused by canine distemper virus and as an aid in the prevention of disease caused by canine adenovirus (both infectious canine hepatitis and infectious tracheobronchitis) for up to 3 years following initial and booster vaccinations. Protection against CAV-2 was demonstrated by serological response in dogs at 36 months following vaccination.

Nobivac Canine 3-DA Dosage And Administration

Aseptically reconstitute the desiccated vaccine with the sterile diluent provided and administer 1mL by the subcutaneous route. Initial vaccination of healthy dogs may be given as early as 7 weeks of age, with booster injections administered every 3-4 weeks until the dog is 12 weeks of age. Dogs over 12 weeks of age should initially receive 2 doses 3-4 weeks apart. Revaccinate every three years with a single dose thereafter.

Following the advice of the American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships.

Precautions

- Store at 2° - 7°C (35°-45°F).

- Do not freeze.

- Shake well before use.

- Use contents promptly once reconstituted.

- Use new, non-chemically sterilized needles and syringes.

- Burn vaccine container and all unused contents.

- Contains gentamicin as a preservative.

- Vaccinate only healthy, non-parasitized dogs.

- Do not vaccinate pregnant bitches.

- The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions.

Antidote

Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

Intervet Inc., Omaha, NE 68103 USA

U.S. Veterinary License No. 165A

1 888 306-0069 (Canada)

25x1 DOSE

102342-01 AL509

Nac No.

12082332